Skip to main content
. 2022 Apr 23;2022:7267937. doi: 10.1155/2022/7267937

Figure 5.

Figure 5

Kaplan-Meier survival analysis revealed significantly increased all/cardiovascular mortality in high-admission CysC cohort with AMI at the end of the 4-year follow-up. (a) Kaplan-Meier survival analysis revealed high-admission CysC cohort (CysC ≥ 1.09 mg/L) displayed significantly increased cardiovascular mortality (HR = 3.016, 95% CI 1.694 to 5.371, p = 0.0002) than controls (CysC < 1.09 mg/L). (b) Kaplan-Meier survival analysis revealed high-admission CysC cohort (CysC ≥ 1.09 mg/L) displayed significantly increased and all-cause mortality (HR = 3.424, 95% CI 2.010 to 5.835, p < 0.0001) than controls (CysC < 1.09 mg/L).